首页/数据集/CHRONIC OBSTRUCTIVE PULMONARY DISEASE: AN ANALYSIS OF ONLINE PATIENT TESTIMONY ON INHALED TREATMENT ADHERENCE

CHRONIC OBSTRUCTIVE PULMONARY DISEASE: AN ANALYSIS OF ONLINE PATIENT TESTIMONY ON INHALED TREATMENT ADHERENCE

Mendeley Data2026-04-18 收录

慢性阻塞性肺疾病

用药依从性

数据链接：

https://data.mendeley.com/datasets/xwthcxbtjs 数据链接链接失效反馈

官方服务：

资源简介：

Research data: - List of codes assigned to quotes (inhaled treatment family) - Inhaled Treatment Network - Analysis

应用场景：

创建时间：

2025-01-27

生物信息学

慢性阻塞性肺疾病

Additional file 6: Table S5. The table ontains the results for the enrichment analyses using different sets of genes.

DataCite Commons2022-03-25 更新50

Characteristics of hospitalized diabetic patients with and without COPD history.

糖尿病共病研究

慢性阻塞性肺疾病

Characteristics of hospitalized diabetic patients with and without COPD history.

Figshare2017-08-17 更新20

Medication of non-retention patients between 6 and 12 months after starting treatment.

用药依从性

患者治疗保留

Chi-squared test for p-values;*p#p@pMedication of non-retention patients between 6 and 12 months after starting treatment.

Figshare2015-12-02 更新00

Data_Sheet_1_Adherence and persistence to oral anticoagulants in patients with atrial fibrillation: A Belgian nationwide cohort study.DOCX

心房颤动治疗

用药依从性

BackgroundSince non-vitamin K antagonist oral anticoagulants (NOACs) do not require coagulation monitoring, concerns of lower adherence and persistence to NOACs than vitamin K antagonists (VKAs) have

NIAID Data Ecosystem40

Supplementary Material for: Anti-Inflammatory Activity of Ensifentrine, a Novel, Selective Dual Inhibitor of Phosphodiesterase (PDE)3 and PDE4

PDE10A抑制剂研究

慢性阻塞性肺疾病

Ensifentrine is a novel, low molecular weight molecule that is a selective, dual inhibitor of phosphodiesterase (PDE)3 and PDE4. Inhibition of PDE3 has been shown to relax airway smooth muscle and inh

Figshare2025-04-17 更新00

CHRONIC OBSTRUCTIVE PULMONARY DISEASE: AN ANALYSIS OF ONLINE PATIENT TESTIMONY ON INHALED TREATMENT ADHERENCE

资源简介：

相关数据集